Gene expression profiling in breast cancer

被引：23

作者：

Sotiriou, C. ^{[1
]}

Desmedt, C. ^{[1
]}

机构：

[1] Inst Jules Bordet, Med Oncol Clin, B-1000 Brussels, Belgium

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷

关键词：

D O I：

10.1093/annonc/mdl270

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：X259 / X262

页数：4

共 28 条

[1] Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer [J].

Ayers, M ;

Symmans, WF ;

Stec, J ;

Damokosh, AI ;

Clark, E ;

Hess, K ;

Lecocke, M ;

Metivier, J ;

Booser, D ;

Ibrahim, N ;

Valero, V ;

Royce, M ;

Arun, B ;

Whitman, G ;

Ross, J ;

Sneige, N ;

Hortobagyi, GN ;

Pusztai, L .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2284-2293

[2]

BUYSE M, IN PRESS J NATL CANC

[3] Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival [J].

Chang, HY ;

Nuyten, DSA ;

Sneddon, JB ;

Hastie, T ;

Tibshirani, R ;

Sorlie, T ;

Dai, HY ;

He, YDD ;

van't Veer, LJ ;

Bartelink, H ;

van de Rijn, M ;

Brown, PO ;

van de Vijver, MJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (10) :3738-3743

[4] Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds [J].

Chang, HY ;

Sneddon, JB ;

Alizadeh, AA ;

Sood, R ;

West, RB ;

Montgomery, K ;

Chi, JT ;

van de Rijn, M ;

Botstein, D ;

Brown, PO .

PLOS BIOLOGY, 2004, 2 (02) :206-214

[5] Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer [J].

Chang, JC ;

Wooten, EC ;

Tsimelzon, A ;

Hilsenbeck, SG ;

Gutierrez, MC ;

Elledge, R ;

Mohsin, S ;

Osborne, CK ;

Chamness, GC ;

Allred, DC ;

O'Connell, P .

LANCET, 2003, 362 (9381) :362-369

[6]

DESMEDT C, 2006, 5 EUR BREAST CANC C

[7]

Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979

[8] PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].

ELSTON, CW ;

ELLIS, IO .

HISTOPATHOLOGY, 1991, 19 (05) :403-410

[9] Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer [J].

Foekens, JA ;

Atkins, D ;

Zhang, Y ;

Sweep, FCGJ ;

Harbeck, N ;

Paradiso, A ;

Cufer, T ;

Sieuwerts, AM ;

Talantov, D ;

Span, PN ;

Tjan-Heijnen, VCG ;

Zito, AF ;

Specht, K ;

Hoefler, H ;

Golouh, R ;

Schittulli, F ;

Schmitt, M ;

Beex, LVAM ;

Klijn, IGM ;

Wang, YX .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (11) :1665-1671

[10] Meeting highlights:: Updated international expert consensus on the primary therapy of early breast cancer [J].

Goldhirsch, A ;

Wood, WC ;

Gelber, RD ;

Coates, AS ;

Thürlimann, B ;

Senn, HJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3357-3365

← 1 2 3 →